You are viewing: France Vendor Neutral Archive (VNA) & PACS Market analysis

The France Vendor Neutral Archive (VNA) & PACS Market was valued at $185.9 Million in 2026 and projected to reach to $299.1 Million by 2031, representing a compound annual growth rate of 10.0%. France's VNA and PACS market is positioned for sustained expansion as healthcare institutions prioritize interoperable imaging solutions aligned with European digital health standards.

France Vendor Neutral Archive (VNA) & PACS Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

France Vendor Neutral Archive (VNA) & PACS Market Trends and Insights

  • This 10.0% compound annual growth rate reflects France's commitment to modernizing healthcare imaging infrastructure and adopting interoperable digital solutions across its medical institutions.
  • France is increasingly investing in VNA and PACS technologies to enhance diagnostic capabilities, streamline clinical workflows, and comply with evolving European healthcare data standards. The French healthcare sector's transition toward vendor-neutral solutions is driven by the need for seamless integration across hospital networks and regional health systems.
  • France's regulatory environment and emphasis on healthcare digitalization are accelerating adoption of advanced imaging archives that reduce vendor lock-in and improve data portability.
  • By 2031, France is expected to solidify its position as a key market for VNA and PACS solutions in Europe, supported by ongoing investments in hospital modernization and digital health infrastructure..

Key Market Statistics

  • CAGR (2026-2031) 10.0% CAGR
  • Market Size, 2026 ~USD 185.9 Million
  • Forecast, 2031 ~USD 299.1 Million
  • Country France

France Vendor Neutral Archive (VNA) & PACS Market Overview

Strong Market Valuation :

France's VNA and PACS market is valued at USD 185.9 million in 2026, demonstrating significant investment in healthcare imaging infrastructure modernization across French medical institutions.

Robust Growth Trajectory :

With a 10% CAGR through 2031, France's market growth outpaces the global average of 8.9%, reflecting accelerated adoption of interoperable digital imaging solutions in French healthcare systems.

Digital Healthcare Transformation :

French healthcare providers are prioritizing vendor-neutral solutions to enhance interoperability, reduce vendor lock-in, and streamline imaging workflows across regional and national healthcare networks.

Projected Market Expansion :

The market is forecasted to reach USD 299.1 million by 2031, representing a 61% increase from 2026, driven by regulatory compliance, digital health initiatives, and modernization of aging imaging infrastructure.

France Vendor Neutral Archive (VNA) & PACS Market Dynamics

  • Government initiatives promoting healthcare digitalization and the adoption of cloud-based archiving solutions are accelerating market growth.
  • French hospitals and diagnostic centers are increasingly recognizing the value of vendor-neutral platforms in reducing operational costs and improving clinical workflows. The 10% CAGR through 2031 reflects France's commitment to modernizing its healthcare imaging ecosystem while maintaining data sovereignty and compliance with GDPR and European healthcare regulations.
  • Investment in AI-integrated PACS solutions and remote diagnostic capabilities will further drive market expansion, particularly in regional healthcare networks seeking to optimize resource allocation and improve patient outcomes across the country..

Related Ecosystem

Diagnostic Imaging

Top Technologies
  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT)
  • CT Scanners
  • Nuclear Imaging
  • Positron Emission Tomography
Top Companies
  • Siemens healthineers
  • PHILIPS HEALTHCARE
  • CANON INC.
  • FUJIFILM Holdings Corporation
  • UNITED IMAGING HEALTHCARE CO., LTD.

    Healthcare It

    Top Technologies
    • Computed Tomography (CT)
    • Machine Learning
    • Magnetic Resonance Imaging (MRI)
    • Natural Language Processing (NLP)
    • Predictive Analytics
    Top Companies
    • CERNER CORPORATION
    • PHILIPS HEALTHCARE
    • Oracle Corporation
    • GE HealthCare Technologies Inc.
    • Siemens healthineers

      Key Takeaways

      • France's VNA & PACS market is valued at USD 185.9 million in 2026 and is forecast to reach USD 299.1 million by 2031, representing a 10.0% CAGR.
      • France is prioritizing vendor-neutral imaging solutions to reduce vendor lock-in and enhance interoperability across its healthcare networks.
      • French healthcare institutions are investing in advanced PACS and VNA technologies to improve diagnostic workflows and comply with European data standards.
      • France's digital health initiatives and hospital modernization programs are key drivers supporting sustained market expansion through 2031.

      Vendor Neutral Archive (VNA) & PACS Market Report Scope

      Report Metric Details
      Base Year 2026
      Fastest Growing Segment INDIA (Modality)
      Forecast Period 2026–2031
      Growth Rate CAGR of 8.9% from 2026 to 2031
      Largest Segment VNA (Product Type)
      Market Size Base Year (Billions) ~USD 5.6 (2026)
      Revenue Forecast (Billions) ~USD 8.57 (2031)
      Segments Covered Product Type, Modality, Deployment Model, Type, Vendor Type, Application, End User, Type 2023–2030

      France Vendor Neutral Archive (VNA) & PACS Market Report Segmentation

      8 segment dimensions are covered across the global market.

      By Product Type

      • Department Vna
      • Multi-Department Vna
      • Multi-Site Vna
      • Pacs
      • Vna

      By Modality

      • Ct
      • Mammography
      • Mri
      • Pet
      • Ultrasound
      • X-Ray

      By Deployment Model

      • Cloud-Based Deployment Model
      • Cloud-Based Deployment Models
      • Hybrid Deployment Models
      • On-Premises Deployment Models

      By Type

      • Department Pacs
      • Department Vna
      • Multi-Department Pacs
      • Multi-Department Vna
      • Multi-Site Pacs
      • Multi-Site Vna

      By Vendor Type

      • Independent Vendors
      • Third-Party Vendors

      By Application

      • Cardiology
      • Neurology
      • Obstetrics & Gynecology
      • Oncology
      • Orthopedic
      • Other Applications

      By End User

      • Ambulatory Surgery Centers
      • Diagnostic Centers
      • Hospitals & Clinics
      • Other End Users

      By Type 2023–2030

      • Department Vna
      • Multi-Department Vna
      • Multi-Site Vna

      Target Audience

      • Healthcare IT Vendors : VNA and PACS solution providers need France-specific market data to identify growth opportunities, benchmark competitive positioning, and develop localized product strategies for French healthcare institutions.
      • Hospital and Diagnostic Center Executives : French healthcare administrators require market insights to evaluate imaging infrastructure investments, assess vendor options, and align technology decisions with national digital health initiatives and regulatory requirements.
      • Healthcare IT Consultants : Consulting firms advising French healthcare organizations need detailed market analysis to provide evidence-based recommendations on VNA and PACS adoption, vendor selection, and implementation strategies.
      • Medical Device Investors : Private equity and venture capital firms targeting France's healthcare sector need market sizing and growth forecasts to evaluate investment opportunities in imaging technology companies and digital health platforms.
      • Healthcare Policy Makers : French government agencies and health authorities benefit from market data to inform digital health policy, infrastructure funding decisions, and regulatory frameworks supporting interoperable imaging systems.

      Key Companies in the France Vendor Neutral Archive (VNA) & PACS Market

      CompanyHQOwnershipStrongest segments
      AGFA-GEVAERT GROUPBelgiumPublic CompanyHealthcare enterprise imaging platform and software,Diagnostic imaging hardware, X-ray and hardcopy film, and DR equipment,Sign & display and packaging printers, inks, and software,
      FUJIFILM HOLDINGS CORPORATIONJapanPublic CompanyHealthcare (medical systems, CDMO, pharma, regenerative, cosmetics/supplements),Electronics (display, semiconductor, storage, industrial equipment, fine chemicals),Business Innovation (office equipment, document solutions, graphic communications),
      SECTRA ABSwedenPublic CompanyImaging IT Solutions (enterprise imaging, PACS/VNA, services),Secure Communications,Business Innovation (orthopedics, medical education, precision diagnostics IT),
      GE HEALTHCAREUnited StatesPublic CompanyImaging (CT, MR, X-ray, Molecular, Women’s Health),Advanced Visualization Solutions & Ultrasound / Image-Guided Therapies,Patient Care Solutions (Monitoring, Cardiology, Maternal Infant, Anesthesia, Digital),
      KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyDiagnosis & Treatment (Imaging and Image-Guided Therapy),Connected Care (Monitoring, Enterprise Informatics, Sleep & Respiratory Care),Personal Health,
      HYLAND SOFTWARE, INC.United StatesPrivate CompanyOnBase platform (ECM, workflow, case management),Healthcare imaging and interoperability (Hyland Healthcare, Acuo, NilRead, PACSgear, Mackinac),Legacy ECM/BPM suites (Perceptive Content, Perceptive Process, Saperion, NolijWeb),
      ASPYRA, LLCUnited StatesPublic CompanyLaboratory information and workflow solutions,Imaging and orthopedic workflow solutions,Hardware, integration, and professional services,

      AGFA-GEVAERT GROUP

      Agfa-Gevaert Group is a Belgian public company established in 1867 with 4,211 employees, operating across imaging and healthcare technology sectors.

      FUJIFILM HOLDINGS CORPORATION

      Fujifilm Holdings Corporation is a Japanese public company founded in 1934 with 73,526 employees, engaged in imaging, healthcare, and materials technology.

      SECTRA AB

      Sectra AB is a Swedish public company established in 1957 with 1,365 employees, specializing in medical imaging and cybersecurity solutions.

      GE HEALTHCARE

      GE Healthcare is a United States-based public company founded in 2022 with 54,000 employees, providing medical imaging and healthcare technology solutions.

      KONINKLIJKE PHILIPS N.V.

      Koninklijke Philips N.V. is a Dutch multinational public company established in 1891 with 64,317 employees, operating in healthcare, lighting, and consumer electronics.

      HYLAND SOFTWARE, INC.

      Hyland Software, Inc. is a United States private company established in 1991 with 336 employees, developing content management and workflow automation solutions.

      ASPYRA, LLC

      Aspyra, LLC is a United States public company founded in 1978 with 70 employees, specializing in healthcare imaging and information management systems.

      Reasons to Buy this Report

      • France-Specific Market Sizing : Access precise valuation data for France's VNA and PACS market with detailed 2026-2031 forecasts, enabling accurate budgeting and investment planning for French healthcare organizations and vendors.
      • Competitive Landscape Intelligence : Understand France's unique vendor ecosystem, regulatory environment, and adoption patterns to identify market opportunities and competitive positioning within the French healthcare imaging sector.
      • Growth Driver Analysis : Identify key factors driving France's 10% CAGR, including government digitalization initiatives, GDPR compliance requirements, and regional healthcare network modernization priorities specific to French institutions.
      • Strategic Market Entry Planning : Leverage France-focused insights to develop targeted go-to-market strategies, partnership opportunities, and product positioning aligned with French healthcare procurement practices and regulatory frameworks.
      • Investment Decision Support : Make informed investment and expansion decisions based on comprehensive France market data, including growth projections, adoption trends, and emerging opportunities in cloud-based and AI-integrated imaging solutions.

      Frequently asked questions

      What is the current market size of VNA and PACS in France?

      France's VNA and PACS market was valued at USD 185.9 million in 2026 and is expected to grow to USD 299.1 million by 2031.

      What is the projected growth rate for France's VNA and PACS market?

      France's VNA and PACS market is projected to grow at a compound annual growth rate (CAGR) of 10.0% from 2026 to 2031.

      Why is France adopting vendor-neutral archive solutions?

      France is adopting VNA solutions to reduce vendor lock-in, improve interoperability across healthcare networks, and comply with European healthcare data standards.

      Which sectors in France are driving VNA and PACS adoption?

      French hospitals, regional health systems, and diagnostic imaging centers are the primary drivers of VNA and PACS adoption as part of broader digital health modernization efforts.

      What regulatory factors influence the VNA and PACS market in France?

      France's healthcare digitalization initiatives, European data protection regulations, and interoperability requirements are key regulatory factors supporting VNA and PACS market growth.

      RESEARCH METHODOLOGY

      The study involved five major activities to estimate the current size of the VNA & PACS market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

      Secondary Research

      In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for the study of the VNA PACS market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

      Primary Research

      Extensive primary research was conducted after acquiring basic knowledge about the VNA & PACS market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital directors, Hospital Vice Presidents, Department heads, and Critical care specialists ) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

      BREAKDOWN OF PRIMARIES

      Vendor Neutral Archive (VNA) & PACS Market
 Size, and Share

      Note 2: Tiers of companies are defined based on their total revenues in 2025. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      Both top-down and bottom-up approaches were used to estimate and validate the total size of the VNA & PACS market. These methods were also used extensively to estimate the size of various subsegments in the market.

      Vendor Neutral Archive (VNA) & PACS Market Top Down and Bottom Up Approach

      Data Triangulation

      After arriving at the overall market size using the market size estimation processes, the market was split into several segments and subsegments. To complete the overall market engineering process and determine the exact statistics for each market segment and sub-segment, data triangulation and market breakdown procedures were employed where applicable. The data was triangulated by examining various factors and trends on both the demand and supply sides of the VNA & PACS market.

      Market Definition

      VNA and PACS are medical imaging technologies that offer cost-effective storage and easy access to images from various modalities. These solutions are essential elements of modern healthcare IT infrastructure, enabling the efficient and secure digitization, storage, retrieval, and sharing of medical imaging data.

      Key Stakeholders

      • VNA & PACS vendors
      • Government bodies
      • Healthcare service providers
      • Clinical/Physician centers
      • Healthcare professionals
      • Health IT service providers
      • Healthcare associations/institutes
      • Ambulatory care centers
      • Venture capitalists
      • Distributors and resellers
      • Maintenance and support service providers
      • Integration service providers
      • Healthcare players

      Report Objectives

      • To define, describe, and forecast the VNA & PACS market based on product type, modality, deployment, vendor type, application, end user, and region
      • To provide detailed information regarding the factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
      • To strategically analyze micromarkets¹ with respect to individual growth trends, prospects, and contributions to the market
      • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of market segments in North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
      • To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies²
      • To track and analyze competitive developments such as product launches and approvals; joint ventures, partnerships, & collaborations; acquisitions; and contracts in the VNA & PACS market.

      Available customizations:

      With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

      • Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company.
      • Geographic Analysis: Further breakdown of Latin America, Europe, and the Middle East & Africa VNA & PACS into specific countries

       

      Get the Full Vendor Neutral Archive (VNA) & PACS Market Report

      Full forecast, segment splits, and company analysis for all Vendor Neutral Archive (VNA) & PACS Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status